Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task

Nicotine can improve attentional functioning in humans, and a number of studies have recently demonstrated that under specific task conditions, nicotine can also improve attention in the rat. Neuronal nicotinic receptors comprise combinations of alpha(2-9) and beta(2-4) subunits, arranged to form a pentameric receptor, with the principal CNS subtypes currently believed to be alpha(4)beta(2) and a homomeric alpha(7) receptor. In the present studies, we attempted to delineate the particular nicotinic receptor subtype(s) contributing to the effects of nicotine on attention by assessing various nicotinic ligands on performance in the five-choice serial reaction time task (5-CSRTT). In rats performing below criterion (<80% correct, >20% omissions to a 1-s visual stimulus), subchronic dosing with nicotine (0.2 mg/kg sc) and the alpha(4)beta(2) agonist SIB 1765F (5 mg/kg sc) increased correct responding and decreased response latencies across the treatment week; whereas the alpha(7) agonist AR-R 17779 (20 mg/kg sc) was without effect. In subjects meeting the criterion, the competitive high affinity (including alpha(4)beta(2)) nicotine receptor antagonist DHbetaE (1-10 mg/kg sc) and the alpha(7) antagonist methyllycaconitine (MLA: 5-10 mg/kg i.p.) did not disrupt performance, whereas at the highest dose, the non-competitive antagonist mecamylamine (0.3-3 mg/kg sc) decreased accuracy and increased response latencies. These changes bore some similarities to those of pre-feeding and the non-competitive NMDA antagonist dizocilpine (0.03-0.06 mg/kg sc), suggesting that mecamylamine-induced performance disruption may relate to non-nicotinic receptor effects. In subjects chronically treated with nicotine, acute nicotine challenge (0.4 mg/kg sc) significantly increased accuracy whilst having no effect on any other performance measures. Finally, in these same nicotine pre-treated rats, the decrease in latency and increase in premature responses induced by nicotine (0.2 mg/kg sc) to a target stimulus of 150 ms was fully antagonised by DHbetaE (3 mg/kg sc) but not MLA (5 mg/kg i.p.). These results suggest that alpha(7) receptors do not play a role in any of the behavioural effects of nicotine observed in the 5-CSRTT, whereas a high affinity site, perhaps alpha(4)beta(2), is more likely involved.

[1]  T. Rao,et al.  Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats. , 1997, The Journal of pharmacology and experimental therapeutics.

[2]  H. Fibiger,et al.  Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: An in vivo microdialysis study , 1991, Pharmacology Biochemistry and Behavior.

[3]  H. Fibiger,et al.  Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli , 1995, Neuroscience.

[4]  E. Levin,et al.  Nicotinic System Involvement in Alzheimer’s and Parkinson’s Diseases , 1997, Drugs & aging.

[5]  S J Heishman,et al.  What aspects of human performance are truly enhanced by nicotine? , 1998, Addiction.

[6]  B. Hahn,et al.  Nicotine in an animal model of attention. , 2000, European journal of pharmacology.

[7]  Andrew P. Smith,et al.  Noradrenaline and attention lapses , 1996, Nature.

[8]  D.N.C. Jones,et al.  Age-associated impairments in a test of attention: evidence for involvement of cholinergic systems , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  A. C. Collins,et al.  UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes , 2000, The Journal of Neuroscience.

[10]  T. Robbins,et al.  Neural Systems Underlying Arousal and Attention: Implications for Drug Abuse a , 1998, Annals of the New York Academy of Sciences.

[11]  I. Stolerman,et al.  The role of nicotinic and muscarinic acetylcholine receptors in attention , 2000, Psychopharmacology.

[12]  B. Martin Nicotine Receptors in the Central Nervous System , 1986 .

[13]  G. Higgins,et al.  Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. , 2000, The Journal of pharmacology and experimental therapeutics.

[14]  Ian P. Stolerman,et al.  Nicotine enhances sustained attention in the rat under specific task conditions , 1998, Psychopharmacology.

[15]  E. Levin,et al.  AR-R 17779, an α7 nicotinic agonist, improves learning and memory in rats , 1999 .

[16]  P. Clarke,et al.  Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons , 1985, Brain Research.

[17]  J. McCarten,et al.  Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety , 1995, Pharmacology Biochemistry and Behavior.

[18]  J. Changeux,et al.  Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders , 1997, Current Opinion in Neurobiology.

[19]  T. Robbins,et al.  Doubly dissociable effects of median- and dorsal-raphé lesions on the performance of the five-choice serial reaction time test of attention in rats , 1997, Behavioural Brain Research.

[20]  C. Luetje,et al.  Determinants of Competitive Antagonist Sensitivity on Neuronal Nicotinic Receptor β Subunits , 1996, The Journal of Neuroscience.

[21]  P. Adams,et al.  Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. , 1997, The Journal of pharmacology and experimental therapeutics.

[22]  T. Robbins,et al.  Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes , 1989, Behavioural Brain Research.

[23]  P. Clarke,et al.  Characterization of the locomotor stimulant action of nicotine in tolerant rats , 1983, British journal of pharmacology.

[24]  T. Robbins,et al.  Central cholinergic systems and cognition. , 1997, Annual review of psychology.

[25]  D. Warburton,et al.  Evaluation of the information processing and mood effects of a transdermal nicotine patch , 1998, Psychopharmacology.

[26]  E. Levin,et al.  Transdermal nicotine effects on attention , 1998, Psychopharmacology.

[27]  J. Rusted,et al.  Effortful processing is a requirement for nicotine-induced improvements in memory , 1998, Psychopharmacology.

[28]  Barry J. Everitt,et al.  Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms , 1997, Psychopharmacology.

[29]  Ezio Tirelli,et al.  Selective effects of nicotine on attentional processes , 1999, Psychopharmacology.

[30]  B. Everitt,et al.  AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  E. Levin,et al.  Nicotinic acetylcholine involvement in cognitive function in animals , 1998, Psychopharmacology.

[32]  B. Potter,et al.  Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors , 1999, Neuropharmacology.

[33]  Trevor W. Robbins,et al.  Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: Implications for theories of selective attention and arousal , 1989, Behavioural Brain Research.

[34]  Agneta Nordberg,et al.  Neuronal nicotinic receptors in the human brain , 2000, Progress in Neurobiology.

[35]  D. Sanger,et al.  The effect of repeated nicotine administration on the performance of drug-naive rats in a five-choice serial reaction time task. , 1999, Behavioural pharmacology.

[36]  E. Levin,et al.  Nicotine–Haloperidol Interactions and Cognitive Performance in Schizophrenics , 1996, Neuropsychopharmacology.

[37]  L. Wilkinson,et al.  Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype , 1999, The European journal of neuroscience.

[38]  T. Robbins,et al.  Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal , 1983, Behavioural Brain Research.

[39]  J. Changeux,et al.  Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function. , 2000, European journal of pharmacology.

[40]  M. Delong,et al.  A reappraisal of the functions of the nucleus basalis of Meynert , 1988, Trends in Neurosciences.

[41]  L. Epstein,et al.  Conditioned tolerance to the heart rate effects of smoking , 1991, Pharmacology Biochemistry and Behavior.

[42]  L. Role,et al.  Nicotinic Receptors in the Development and Modulation of CNS Synapses , 1996, Neuron.

[43]  P. Soubrié,et al.  A simple model for studying benzodiazepines: Potentiation of hyperactivity induced by cocaine in mice , 1982 .

[44]  J. Sirviö,et al.  Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion , 2000, Psychopharmacology.

[45]  J. McIntosh,et al.  α-Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal Synaptosomes , 1997, The Journal of Neuroscience.

[46]  D. Sanger,et al.  Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies , 2000, Psychopharmacology.

[47]  P. Clarke,et al.  The effects of nicotine on locomotor activity in non‐tolerant and tolerant rats , 1983, British journal of pharmacology.

[48]  B. Christensen,et al.  Mecamylamine is a selective non-competitive antagonist of N-methyl-d-aspartate- and aspartate-induced currents in horizontal cells dissociated from the catfish retina , 1988, Neuroscience Letters.

[49]  H. Fibiger,et al.  Enhanced acetylcholine release in hippocampus and cortex during the anticipation and consumption of a palatable meal , 1994, Neuroscience.

[50]  B. Sahakian,et al.  The Effects of Nicotine on Attention, Information Processing, and Short-Term Memory in Patients with Dementia of the Alzheimer Type , 1989, British Journal of Psychiatry.

[51]  P. Sanberg,et al.  Nicotine for the treatment of Tourette's syndrome. , 1997, Pharmacology & therapeutics.

[52]  J. Muir,et al.  The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. , 1996, Cerebral cortex.

[53]  E. Levin,et al.  Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer’s disease , 1999, Psychopharmacology.

[54]  M. Benwell,et al.  The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity , 1992, British journal of pharmacology.

[55]  E D Levin,et al.  Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). , 1996, Psychopharmacology bulletin.

[56]  Bradley V. Clineschmidt,et al.  Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties , 2022 .

[57]  G. Koob,et al.  Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. , 2000, The Journal of pharmacology and experimental therapeutics.

[58]  J. Rusted,et al.  Cholinergic control of cognitive resources. , 1993, Neuropsychobiology.

[59]  I. Stolerman Inter-species consistency in the behavioural pharmacology of nicotine dependence. , 1999, Behavioural pharmacology.

[60]  I. Stolerman,et al.  Selective antagonism of behavioural effects of nicotine by dihydro-β-erythroidine in rats , 1997, Psychopharmacology.

[61]  J P Changeux,et al.  International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. , 1999, Pharmacological reviews.

[62]  E. Rolls,et al.  Neuronal responses related to reinforcement in the primate basal forebrain , 1990, Brain Research.